VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, ...

VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, I ...

Onco-Innovations views this Expression of Interest as a strong validation of the PROmAI initiative's relevance and potential impact in the rapidly evolving field of oncology R&D.

Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025 Provided by ACCESS Newswire Jun 25, 2025, 10:00:00 PM.

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through ...

Conference ID: ONCO. The Company will issue a press release after the conclusion of the conference call. About Onco-Innovations Limited. Onco-Innovations is a Canadian-based company dedicated to ...

Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025 ...

or. Participant Toll-Free Number: 888-304-1803 International / Direct Dial: 848-488-9277 Germany: +49 69 5899 64215. Conference ID: ONCO. The Company will issue a press release after the ...

A high-level overview of Onco-Innovations Limited (ONCO:CA) stock. View (ONCO:CA) real-time stock price, chart, news, analysis, analyst reviews and more.

In an extraordinary demonstration of surgical expertise, doctors at Jehangir Hospital, Pune, successfully removed an ...

Regeneron's Dupixent leads growth as Eylea sales decline and valuation is attractive, but growth is delayed by 2-3 years.